Latest from Epigraph
Telemedicina para la atención de la epilepsia: pasado, presente y futuro¿La telemedicina para el cuidado de la epilepsia es más popular que nunca. Tiene muchas ventajas, pero ¿Puede sostenerse en el futuro? |
||
New-onset refractory status epilepticus (NORSE)NORSE is a rare medical emergency involving persistent seizures in someone without a history of epilepsy. Many cases appear preceded by a mild, flu-like illness. The most common identified cause of NORSE is autoimmune encephalitis; research suggests that immunotherapy should be considered when no cause is found. To learn more, listen to our podcast. |
||
More from Epigraph:Will the pandemic give a permanent boost to telemedicine for epilepsy? Setting the record straight on the chances of seizure freedom after two medications fail Can community-based interventions help to close the epilepsy treatment gap? Forced changes and creative solutions: The pandemic’s effects on epilepsy research Second-line treatment for status epilepticus: What’s the latest? |
||
Because of the GDPR, we have had to restrict our email distribution list, and we may no longer be able to reach everyone who may have an interest. Please feel free to share this email with others who may be interested. |